Discovery of HCD3514 as a potent EGFR inhibitor against C797S mutation in vitro and in vivo

Osimertinib (AZD9291), a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI), has significantly improved the survival of non-small cell lung cancer (NSCLC) patients with EGFR(T790M) mutation, the major mechanism of acquired resistance to first-generation EGFR TK...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Mengzhen, Zhang, Tao, Chen, Hao, Song, Peiran, Tong, Linjiang, Chen, Jiaying, Liu, Yingqiang, Ning, Yi, Feng, Fang, Li, Yan, Tang, Haotian, Chen, Yi, Fang, Yan, Lu, Xiaoyun, Geng, Meiyu, Ding, Ke, Yu, Ker, Ding, Jian, Xie, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809337/
https://www.ncbi.nlm.nih.gov/pubmed/36605493
http://dx.doi.org/10.7150/jca.77788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809337/
https://www.ncbi.nlm.nih.gov/pubmed/36605493
http://dx.doi.org/10.7150/jca.77788

Ejemplares similares